BRKR vs FTV

For growth investors, Bruker Corporation (BRKR) is the stronger pick with 2.

1% revenue growth year-over-year, versus -17. 5% for Fortive Corporation (FTV). Fortive Corporation (FTV) offers the better valuation at 34. 7x trailing P/E (20. 4x forward), making it the more compelling value choice. Analysts rate Bruker Corporation (BRKR) a "Buy" — based on 32 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, Bruker Corporation is actually cheaper at 20.

0x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Fortive Corporation (FTV) delivered a total return of +12.

7%, compared to -36. 6% for Bruker Corporation (BRKR). Over 10 years, the gap is even starker: FTV returned +103. 5% versus BRKR's +59. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Fortive Corporation (FTV) is the lower-risk stock at 0.

83β versus Bruker Corporation's 1. 59β — meaning BRKR is approximately 92% more volatile than FTV relative to the S&P 500. On balance sheet safety, Fortive Corporation (FTV) carries a lower debt/equity ratio of 50% versus 81% for Bruker Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Bruker Corporation (BRKR) is pulling ahead at 2.

1% versus -17. 5% for Fortive Corporation (FTV). On earnings-per-share growth, the picture is similar: Fortive Corporation grew EPS -26. 3% year-over-year, compared to -119. 7% for Bruker Corporation. Over a 3-year CAGR, BRKR leads at 10. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Fortive Corporation (FTV) is the more profitable company, earning 11.

3% net margin versus -0. 3% for Bruker Corporation — meaning it keeps 11. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: FTV leads at 17. 7% versus 6. 9% for BRKR. At the gross margin level — before operating expenses — FTV leads at 61. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Bruker Corporation (BRKR) trades at 20.

0x forward P/E versus 20. 4x for Fortive Corporation — 0. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BRKR: 23. 2% to $52. 13.

All stocks in this comparison pay dividends.

Fortive Corporation (FTV) offers the highest yield at 0. 5%, versus 0. 4% for Bruker Corporation (BRKR).

For long-horizon retirement investors, Fortive Corporation (FTV) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

83), +103. 5% 10Y return). Bruker Corporation (BRKR) carries a higher beta of 1. 59 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (FTV: +103. 5%, BRKR: +59. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (BRKR (Healthcare) and FTV (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.